Does GABAPENTIN Cause Product dose omission issue? 391 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 391 reports of Product dose omission issue have been filed in association with GABAPENTIN (Gabapentin). This represents 0.5% of all adverse event reports for GABAPENTIN.
391
Reports of Product dose omission issue with GABAPENTIN
0.5%
of all GABAPENTIN reports
33
Deaths
111
Hospitalizations
How Dangerous Is Product dose omission issue From GABAPENTIN?
Of the 391 reports, 33 (8.4%) resulted in death, 111 (28.4%) required hospitalization, and 31 (7.9%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GABAPENTIN. However, 391 reports have been filed with the FAERS database.
What Other Side Effects Does GABAPENTIN Cause?
Drug ineffective (10,914)
Drug hypersensitivity (6,833)
Off label use (6,729)
Drug ineffective for unapproved indication (5,231)
Product use in unapproved indication (4,919)
Toxicity to various agents (4,839)
Completed suicide (4,111)
Dizziness (4,107)
Somnolence (3,798)
Fatigue (3,791)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which GABAPENTIN Alternatives Have Lower Product dose omission issue Risk?
GABAPENTIN vs GABAPENTIN ENACARBIL
GABAPENTIN vs GADAVIST
GABAPENTIN vs GADOBENATE DIMEGLUMINE
GABAPENTIN vs GADOBUTROL
GABAPENTIN vs GADODIAMIDE